Our Open Innovation Approach

Throughout the R&D process, from bench to clinic and into the marketplace, we take a ‘Science First’ approach to optimize the chances of creating new treatment options and value for patients with high unmet needs. ‘Science First’ means we focus on the best science, empower the best talent to pursue it, and develop it at the best location. 

For our experienced scientists, we support bold, pragmatic thinking, facilitate smart risk-taking and encourage strong and ethical decision-making through all stages and aspects of development. For our partners and collaborators, we take an open and pragmatic approach to innovation, offering unique levels of support and knowledge sharing, and where appropriate, incubating projects at our partner sites led by our partner teams. 

We build partnerships with organizations and companies that share our approach, complement our expertise and can help us accelerate ground-breaking science in new technologies across multiple therapeutic areas. We combine the experience, expertise and resources of an established company with the agility, flexibility and tenacity of a start-up, making Astellas an ideal partner for ambitious biotechnology and health technology organizations pursuing partnership and/or acquisition to accelerate their progress.

By focusing on the science of innovative technology platforms and new treatment modalities first, then seeking to apply them across a broad range of diseases, we maximize our potential to capture innovation, support treatment and benefit patients. Our current pipeline includes potential treatments in oncology, urology and nephrology, immunology and neuroscience, while also advancing new areas of discovery research in areas such as ophthalmology and muscle diseases.